Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head and Neck Cancer

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Procedure: Computed Tomography;   Procedure: Lymphoscintigraphy;   Drug: Panitumumab-IRDye800;   Other: Pharmacological Study;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc 99m-labeled Tilmanocept
Sponsors:   Eben Rosenthal;   National Cancer Institute (NCI)
Not yet recruiting

http://ift.tt/2mUw3no